<p>Deep Longevity’s new US telehealth platform, Accrua, ties treatment plans to a blood-based aging score and re-tests every quarter. A routine blood test is about to sit at the center of a new US telehealth service, and the pitch is that your blood knows your age better than you do. Hong Kong-listed R</p>